A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors.
Invest New Drugs
; 31(2): 409-16, 2013 Apr.
Article
en En
| MEDLINE
| ID: mdl-23242861
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Quinazolinas
/
Neoplasias
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Invest New Drugs
Año:
2013
Tipo del documento:
Article
País de afiliación:
Estados Unidos